載入...
Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can lead to a variety of clinical outcomes, ranging from the absence of symptoms to severe acute respiratory disease and ultimately death. A feature of patients with severe coronavirus disease 2019 (COVID-19) is the a...
Na minha lista:
| 發表在: | J Allergy Clin Immunol |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8180473/ https://ncbi.nlm.nih.gov/pubmed/34111453 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2021.05.032 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|